Our studies indicate that the recipient T cell IL-4 and Th2 regulatory loop and TGF-β production promote recipient T cell survival, mimicking mixed chimerism, and regulate GVHD after myeloablative preparation (TBI) and also prevent tumor growth by preserving the graft-versus-tumor effect (18). Here, TGFB1 is linked to neoplasm.